ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Latent TB Infection Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-21E8563
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Latent TB Infection Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global Latent TB Infection Testing Market Research Report 2025

Code: QYRE-Auto-21E8563
Report
September 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
Pharmstandard (Generium Pharmaceutical)
Sanofi S.A./Sanofi Pasteur Ltd.
Statens Serum Institut (SSI)
Autoimmun Diagnostika (AID) GmbH
Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
Immunoshop India Pvt Ltd.
QIAGEN N V
Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
SD BIOSENSOR, Inc.

Latent TB Infection Testing Market

The global market for Latent TB Infection Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The main ways to diagnose LTBI are by placing a tuberculin skin test (TST) on the forearm or by getting a TB blood test, in addition to obtaining a chest radiograph (x-ray) if either one of these tests is positive. One-third of the world"s population has LTBI. The TB germs are dormant (asleep) in the body.
North American market for Latent TB Infection Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Latent TB Infection Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Latent TB Infection Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Latent TB Infection Testing include Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC), Pharmstandard (Generium Pharmaceutical), Sanofi S.A./Sanofi Pasteur Ltd., Statens Serum Institut (SSI), Autoimmun Diagnostika (AID) GmbH, Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., Haikou VTI Biological Institute (Vaccine Technologies, Inc.), Immunoshop India Pvt. Ltd., Qiagen N.V., Quest Diagnostics, Inc. (Oxford Immunotec Global plc), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Latent TB Infection Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent TB Infection Testing.
The Latent TB Infection Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Latent TB Infection Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latent TB Infection Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Latent TB Infection Testing Market Report

Report Metric Details
Report Name Latent TB Infection Testing Market
Segment by Type
  • Mantoux Test / Tuberculin Skin Test (TST)
  • Interferon-Gamma Release Assay (IGRA)
Segment by Application
  • Hospitals
  • Public and Student Health
  • Physician Offices and Clinics
  • Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC), Pharmstandard (Generium Pharmaceutical), Sanofi S.A./Sanofi Pasteur Ltd., Statens Serum Institut (SSI), Autoimmun Diagnostika (AID) GmbH, Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., Haikou VTI Biological Institute (Vaccine Technologies, Inc.), Immunoshop India Pvt. Ltd., Qiagen N.V., Quest Diagnostics, Inc. (Oxford Immunotec Global plc), SD Biosensor, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Latent TB Infection Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Latent TB Infection Testing Market report?

Ans: The main players in the Latent TB Infection Testing Market are Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC), Pharmstandard (Generium Pharmaceutical), Sanofi S.A./Sanofi Pasteur Ltd., Statens Serum Institut (SSI), Autoimmun Diagnostika (AID) GmbH, Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., Haikou VTI Biological Institute (Vaccine Technologies, Inc.), Immunoshop India Pvt. Ltd., Qiagen N.V., Quest Diagnostics, Inc. (Oxford Immunotec Global plc), SD Biosensor, Inc.

What are the Application segmentation covered in the Latent TB Infection Testing Market report?

Ans: The Applications covered in the Latent TB Infection Testing Market report are Hospitals, Public and Student Health, Physician Offices and Clinics, Others (Military, Correctional Facilities, Chronic Care Homes, and Others)

What are the Type segmentation covered in the Latent TB Infection Testing Market report?

Ans: The Types covered in the Latent TB Infection Testing Market report are Mantoux Test / Tuberculin Skin Test (TST), Interferon-Gamma Release Assay (IGRA)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent TB Infection Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Mantoux Test / Tuberculin Skin Test (TST)
1.2.3 Interferon-Gamma Release Assay (IGRA)
1.3 Market by Application
1.3.1 Global Latent TB Infection Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Public and Student Health
1.3.4 Physician Offices and Clinics
1.3.5 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Latent TB Infection Testing Market Perspective (2020-2031)
2.2 Global Latent TB Infection Testing Growth Trends by Region
2.2.1 Global Latent TB Infection Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Latent TB Infection Testing Historic Market Size by Region (2020-2025)
2.2.3 Latent TB Infection Testing Forecasted Market Size by Region (2026-2031)
2.3 Latent TB Infection Testing Market Dynamics
2.3.1 Latent TB Infection Testing Industry Trends
2.3.2 Latent TB Infection Testing Market Drivers
2.3.3 Latent TB Infection Testing Market Challenges
2.3.4 Latent TB Infection Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent TB Infection Testing Players by Revenue
3.1.1 Global Top Latent TB Infection Testing Players by Revenue (2020-2025)
3.1.2 Global Latent TB Infection Testing Revenue Market Share by Players (2020-2025)
3.2 Global Latent TB Infection Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Latent TB Infection Testing Revenue
3.4 Global Latent TB Infection Testing Market Concentration Ratio
3.4.1 Global Latent TB Infection Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent TB Infection Testing Revenue in 2024
3.5 Global Key Players of Latent TB Infection Testing Head office and Area Served
3.6 Global Key Players of Latent TB Infection Testing, Product and Application
3.7 Global Key Players of Latent TB Infection Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent TB Infection Testing Breakdown Data by Type
4.1 Global Latent TB Infection Testing Historic Market Size by Type (2020-2025)
4.2 Global Latent TB Infection Testing Forecasted Market Size by Type (2026-2031)
5 Latent TB Infection Testing Breakdown Data by Application
5.1 Global Latent TB Infection Testing Historic Market Size by Application (2020-2025)
5.2 Global Latent TB Infection Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Latent TB Infection Testing Market Size (2020-2031)
6.2 North America Latent TB Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Latent TB Infection Testing Market Size by Country (2020-2025)
6.4 North America Latent TB Infection Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Latent TB Infection Testing Market Size (2020-2031)
7.2 Europe Latent TB Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Latent TB Infection Testing Market Size by Country (2020-2025)
7.4 Europe Latent TB Infection Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latent TB Infection Testing Market Size (2020-2031)
8.2 Asia-Pacific Latent TB Infection Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Latent TB Infection Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Latent TB Infection Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Latent TB Infection Testing Market Size (2020-2031)
9.2 Latin America Latent TB Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Latent TB Infection Testing Market Size by Country (2020-2025)
9.4 Latin America Latent TB Infection Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent TB Infection Testing Market Size (2020-2031)
10.2 Middle East & Africa Latent TB Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Latent TB Infection Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Latent TB Infection Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
11.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Details
11.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
11.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Introduction
11.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue in Latent TB Infection Testing Business (2020-2025)
11.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Development
11.2 Pharmstandard (Generium Pharmaceutical)
11.2.1 Pharmstandard (Generium Pharmaceutical) Company Details
11.2.2 Pharmstandard (Generium Pharmaceutical) Business Overview
11.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Introduction
11.2.4 Pharmstandard (Generium Pharmaceutical) Revenue in Latent TB Infection Testing Business (2020-2025)
11.2.5 Pharmstandard (Generium Pharmaceutical) Recent Development
11.3 Sanofi S.A./Sanofi Pasteur Ltd.
11.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Company Details
11.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
11.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Introduction
11.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Revenue in Latent TB Infection Testing Business (2020-2025)
11.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Recent Development
11.4 Statens Serum Institut (SSI)
11.4.1 Statens Serum Institut (SSI) Company Details
11.4.2 Statens Serum Institut (SSI) Business Overview
11.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Introduction
11.4.4 Statens Serum Institut (SSI) Revenue in Latent TB Infection Testing Business (2020-2025)
11.4.5 Statens Serum Institut (SSI) Recent Development
11.5 Autoimmun Diagnostika (AID) GmbH
11.5.1 Autoimmun Diagnostika (AID) GmbH Company Details
11.5.2 Autoimmun Diagnostika (AID) GmbH Business Overview
11.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Introduction
11.5.4 Autoimmun Diagnostika (AID) GmbH Revenue in Latent TB Infection Testing Business (2020-2025)
11.5.5 Autoimmun Diagnostika (AID) GmbH Recent Development
11.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
11.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Details
11.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
11.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Introduction
11.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue in Latent TB Infection Testing Business (2020-2025)
11.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Development
11.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
11.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Details
11.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
11.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Introduction
11.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue in Latent TB Infection Testing Business (2020-2025)
11.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Development
11.8 Immunoshop India Pvt. Ltd.
11.8.1 Immunoshop India Pvt. Ltd. Company Details
11.8.2 Immunoshop India Pvt. Ltd. Business Overview
11.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Introduction
11.8.4 Immunoshop India Pvt. Ltd. Revenue in Latent TB Infection Testing Business (2020-2025)
11.8.5 Immunoshop India Pvt. Ltd. Recent Development
11.9 Qiagen N.V.
11.9.1 Qiagen N.V. Company Details
11.9.2 Qiagen N.V. Business Overview
11.9.3 Qiagen N.V. Latent TB Infection Testing Introduction
11.9.4 Qiagen N.V. Revenue in Latent TB Infection Testing Business (2020-2025)
11.9.5 Qiagen N.V. Recent Development
11.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
11.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Details
11.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
11.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Introduction
11.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue in Latent TB Infection Testing Business (2020-2025)
11.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Development
11.11 SD Biosensor, Inc.
11.11.1 SD Biosensor, Inc. Company Details
11.11.2 SD Biosensor, Inc. Business Overview
11.11.3 SD Biosensor, Inc. Latent TB Infection Testing Introduction
11.11.4 SD Biosensor, Inc. Revenue in Latent TB Infection Testing Business (2020-2025)
11.11.5 SD Biosensor, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
Pharmstandard (Generium Pharmaceutical)
Sanofi S.A./Sanofi Pasteur Ltd.
Statens Serum Institut (SSI)
Autoimmun Diagnostika (AID) GmbH
Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
Immunoshop India Pvt Ltd.
QIAGEN N V
Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
SD BIOSENSOR, Inc.
List of Tables
 Table 1. Global Latent TB Infection Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Mantoux Test / Tuberculin Skin Test (TST)
 Table 3. Key Players of Interferon-Gamma Release Assay (IGRA)
 Table 4. Global Latent TB Infection Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Latent TB Infection Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Latent TB Infection Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Latent TB Infection Testing Market Share by Region (2020-2025)
 Table 8. Global Latent TB Infection Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Latent TB Infection Testing Market Share by Region (2026-2031)
 Table 10. Latent TB Infection Testing Market Trends
 Table 11. Latent TB Infection Testing Market Drivers
 Table 12. Latent TB Infection Testing Market Challenges
 Table 13. Latent TB Infection Testing Market Restraints
 Table 14. Global Latent TB Infection Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Latent TB Infection Testing Market Share by Players (2020-2025)
 Table 16. Global Top Latent TB Infection Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent TB Infection Testing as of 2024)
 Table 17. Ranking of Global Top Latent TB Infection Testing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Latent TB Infection Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Latent TB Infection Testing, Headquarters and Area Served
 Table 20. Global Key Players of Latent TB Infection Testing, Product and Application
 Table 21. Global Key Players of Latent TB Infection Testing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Latent TB Infection Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Latent TB Infection Testing Revenue Market Share by Type (2020-2025)
 Table 25. Global Latent TB Infection Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Latent TB Infection Testing Revenue Market Share by Type (2026-2031)
 Table 27. Global Latent TB Infection Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Latent TB Infection Testing Revenue Market Share by Application (2020-2025)
 Table 29. Global Latent TB Infection Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Latent TB Infection Testing Revenue Market Share by Application (2026-2031)
 Table 31. North America Latent TB Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Latent TB Infection Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Latent TB Infection Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Latent TB Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Latent TB Infection Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Latent TB Infection Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Latent TB Infection Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Latent TB Infection Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Latent TB Infection Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Latent TB Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Latent TB Infection Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Latent TB Infection Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Latent TB Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Latent TB Infection Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Latent TB Infection Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Details
 Table 47. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Business Overview
 Table 48. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product
 Table 49. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue in Latent TB Infection Testing Business (2020-2025) & (US$ Million)
 Table 50. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Recent Development
 Table 51. Pharmstandard (Generium Pharmaceutical) Company Details
 Table 52. Pharmstandard (Generium Pharmaceutical) Business Overview
 Table 53. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product
 Table 54. Pharmstandard (Generium Pharmaceutical) Revenue in Latent TB Infection Testing Business (2020-2025) & (US$ Million)
 Table 55. Pharmstandard (Generium Pharmaceutical) Recent Development
 Table 56. Sanofi S.A./Sanofi Pasteur Ltd. Company Details
 Table 57. Sanofi S.A./Sanofi Pasteur Ltd. Business Overview
 Table 58. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product
 Table 59. Sanofi S.A./Sanofi Pasteur Ltd. Revenue in Latent TB Infection Testing Business (2020-2025) & (US$ Million)
 Table 60. Sanofi S.A./Sanofi Pasteur Ltd. Recent Development
 Table 61. Statens Serum Institut (SSI) Company Details
 Table 62. Statens Serum Institut (SSI) Business Overview
 Table 63. Statens Serum Institut (SSI) Latent TB Infection Testing Product
 Table 64. Statens Serum Institut (SSI) Revenue in Latent TB Infection Testing Business (2020-2025) & (US$ Million)
 Table 65. Statens Serum Institut (SSI) Recent Development
 Table 66. Autoimmun Diagnostika (AID) GmbH Company Details
 Table 67. Autoimmun Diagnostika (AID) GmbH Business Overview
 Table 68. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product
 Table 69. Autoimmun Diagnostika (AID) GmbH Revenue in Latent TB Infection Testing Business (2020-2025) & (US$ Million)
 Table 70. Autoimmun Diagnostika (AID) GmbH Recent Development
 Table 71. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Details
 Table 72. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Business Overview
 Table 73. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product
 Table 74. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue in Latent TB Infection Testing Business (2020-2025) & (US$ Million)
 Table 75. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Recent Development
 Table 76. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Details
 Table 77. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Business Overview
 Table 78. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product
 Table 79. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue in Latent TB Infection Testing Business (2020-2025) & (US$ Million)
 Table 80. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Recent Development
 Table 81. Immunoshop India Pvt. Ltd. Company Details
 Table 82. Immunoshop India Pvt. Ltd. Business Overview
 Table 83. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product
 Table 84. Immunoshop India Pvt. Ltd. Revenue in Latent TB Infection Testing Business (2020-2025) & (US$ Million)
 Table 85. Immunoshop India Pvt. Ltd. Recent Development
 Table 86. Qiagen N.V. Company Details
 Table 87. Qiagen N.V. Business Overview
 Table 88. Qiagen N.V. Latent TB Infection Testing Product
 Table 89. Qiagen N.V. Revenue in Latent TB Infection Testing Business (2020-2025) & (US$ Million)
 Table 90. Qiagen N.V. Recent Development
 Table 91. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Details
 Table 92. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Business Overview
 Table 93. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product
 Table 94. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue in Latent TB Infection Testing Business (2020-2025) & (US$ Million)
 Table 95. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Recent Development
 Table 96. SD Biosensor, Inc. Company Details
 Table 97. SD Biosensor, Inc. Business Overview
 Table 98. SD Biosensor, Inc. Latent TB Infection Testing Product
 Table 99. SD Biosensor, Inc. Revenue in Latent TB Infection Testing Business (2020-2025) & (US$ Million)
 Table 100. SD Biosensor, Inc. Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Latent TB Infection Testing Picture
 Figure 2. Global Latent TB Infection Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Latent TB Infection Testing Market Share by Type: 2024 VS 2031
 Figure 4. Mantoux Test / Tuberculin Skin Test (TST) Features
 Figure 5. Interferon-Gamma Release Assay (IGRA) Features
 Figure 6. Global Latent TB Infection Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Latent TB Infection Testing Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Public and Student Health Case Studies
 Figure 10. Physician Offices and Clinics Case Studies
 Figure 11. Others (Military, Correctional Facilities, Chronic Care Homes, and Others) Case Studies
 Figure 12. Latent TB Infection Testing Report Years Considered
 Figure 13. Global Latent TB Infection Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Latent TB Infection Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Latent TB Infection Testing Market Share by Region: 2024 VS 2031
 Figure 16. Global Latent TB Infection Testing Market Share by Players in 2024
 Figure 17. Global Top Latent TB Infection Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent TB Infection Testing as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Latent TB Infection Testing Revenue in 2024
 Figure 19. North America Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Latent TB Infection Testing Market Share by Country (2020-2031)
 Figure 21. United States Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Latent TB Infection Testing Market Share by Country (2020-2031)
 Figure 25. Germany Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Latent TB Infection Testing Market Share by Region (2020-2031)
 Figure 33. China Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Latent TB Infection Testing Market Share by Country (2020-2031)
 Figure 41. Mexico Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Latent TB Infection Testing Market Share by Country (2020-2031)
 Figure 45. Turkey Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Latent TB Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Revenue Growth Rate in Latent TB Infection Testing Business (2020-2025)
 Figure 49. Pharmstandard (Generium Pharmaceutical) Revenue Growth Rate in Latent TB Infection Testing Business (2020-2025)
 Figure 50. Sanofi S.A./Sanofi Pasteur Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2020-2025)
 Figure 51. Statens Serum Institut (SSI) Revenue Growth Rate in Latent TB Infection Testing Business (2020-2025)
 Figure 52. Autoimmun Diagnostika (AID) GmbH Revenue Growth Rate in Latent TB Infection Testing Business (2020-2025)
 Figure 53. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2020-2025)
 Figure 54. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Revenue Growth Rate in Latent TB Infection Testing Business (2020-2025)
 Figure 55. Immunoshop India Pvt. Ltd. Revenue Growth Rate in Latent TB Infection Testing Business (2020-2025)
 Figure 56. Qiagen N.V. Revenue Growth Rate in Latent TB Infection Testing Business (2020-2025)
 Figure 57. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Revenue Growth Rate in Latent TB Infection Testing Business (2020-2025)
 Figure 58. SD Biosensor, Inc. Revenue Growth Rate in Latent TB Infection Testing Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Latent Tuberculosis Infection Detection Market Research Report 2024
Global Latent TB Detection Market Research Report 2024
Latent Tuberculosis Infection Screening Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Latent Tuberculosis Infection LTBI Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculin Skin Test TST Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Testing and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tuberculosis TB Diagnostics Market Research Report 2025
Tuberculosis Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Latent tuberculosis Testing Market Research Report 2024
Global Tuberculin Market Research Report 2025
Global Mycobacterium Tuberculosis Testing Market Research Report 2024
Global Tuberculosis TB Detection Market Research Report 2024
Global Tuberculosis Vaccines Market Research Report 2024
Global Fluorescent Antibody Test Market Research Report 2024
Global Human T Lymphotropic Virus HTLV Test Market Research Report 2024
Tuberculosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibiotic Resistance Test Kit Market Research Report 2025
Respiratory Infectious Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global STD Rapid Antibody Test Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions